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Venous blood was drawn from the antecubital veins of normal subjects or from patients with various hereditary coagulative disorders. No. 18-gauge needles coated with Siliclad1 and glass syringes coated with silicone2 were used.
Platelet-deficient citrated plasma was prepared from blood to which one-ninth vol of 0.13 M trisodium citrate had been added (9) unless otherwise noted. Heated, adsorbed plasma was prepared by mixing 10 vol of plasma with 1 vol of aluminum hydroxide gel. 3 This mixture was placed in a Lusteroid container in a 56°C water bath for a hour and then centrifuged for 5 minutes at 3,700 X g in an International refrigerated centrifuge (PR-2) at 2°C. The supernatant plasma was decanted from the precipitated gel. Normal human plasma, prepared in this manner, is deficient in all known clotting factors except PTA (Factor XI) and Hageman factor (Factor XII) (9) . Native plasma, free of extrinsic anticoagulants, was prepared by the method of Conley, Hartmann, and Morse (10) . Plasma prepared this way remained fluid in silicone-coated tubes at 370 C from 40 minutes to more than 48 hours.
Crude PTA was prepared by a previously described method from citrated plasma deficient in Hageman factor (9) . Freshly prepared, the PTA was largely inactive but usually contained some activated PTA; further activation occurred upon storage at -20°C. Partially purified activated PTA was prepared from normal human serum.
As previously described (11) , the carboxymethylcellulose column was washed with a volume of 0.15 M sodium acetate buffer equal to one-half of the original serum. The elution was modified in that 800 ml of a buffer containing equal parts of 0.067 M phosphate buffer (pH 6.8) and 1 M sodium chloride was used (12) . Fractions were collected in 100-ml volumes and were assayed for activated PTA (9) . Those containing the major part of the PTA activity (usually fractions 4 and 5) were combined. The fraction soluble at 33%
and insoluble at 50%o concentration of ammonium sulfate was prepared by addition of a solution of neutral ammonium sulfate saturated at 40 C. The salt was added dropwise with constant stirring until the desired concentration was obtained. The precipitate was dissolved in a volume of 0.067 M sodium phosphate buffer (pH 6.8) equal to one-fiftieth of the original volume of serum. It was dialyzed overnight against 4 L of the same buffer and then lyophilized.
Purified activated Hageman factor was prepared from normal human plasma by a method previously published (13) . This method utilized column chromatography with carboxymethylcellulose and DEAE cellulose, resulting in a product purified 3,000-to 5,000-fold with respect to serum. The lyophilized preparation used contained 10% protein; the remainder of the preparation consisted of salts. Whether all of the Hageman factor in the preparation was in the activated form is not clear (13) . Rabbit brain thromboplastin 4 was prepared by suspending 37 mg of thromboplastin per ml of 0.15 M sodium chloride solution and warming the mixture at 450 C for 10 minutes in accordance with the manufacturer's directions. The thromboplastin was used without filtration. Fatty acids were obtained 5 99 +% pure. They were converted to their sodium salts by gentle warming with sodium hydroxide. Before use, the soaps were diluted with Tris buffer or barbital-saline buffer. The pH of the resulting mixtures was 7.4 to 7.6. The formulas of the fatty acids will be abbreviated according to the formula Cx: y, in which x refers to the number of carbon atoms and y to the number of double bonds. Calciuin stearate (technical grade) was purchased from the manufacturer.6 Trisodium ethylenediaminetetraacetic acid7 was prepared by neutralizing an aqueous solution of the disodium compound with sodium hydroxide to pH 7.0 and diluting it to the desired concentration with water.
Tris buffer (0.15 M, pH 7.4) was prepared from tris (hydroxymethyl) aminomethane. 8 Barbital-saline buffer (pH 7.4) was prepared as described before (14) . Barbital-saline-citrate buffer consisted of a mixture of 85% barbital-saline buffer and 15% 0.13 M trisodium citrate solution.
Dilutions of calcium chloride were made by mixing 0.05 M calcium chloride solution in appropriate amounts of barbital-saline buffer (0.15 M), to maintain a constant ionic strength at different concentrations of calcium ions.
Bovine thrombin 9 was dissolved at a concentration of 1,000 National Institutes of Health U per milliliter in barbital-saline and then diluted further in barbital-saline as needed.
The general technique for measuring the recalcified clotting time was to add appropriate amounts of calcium 6 Fisher Scientific Company, Fair Lawn, N. J. 7 The effect of soap on the activation of Christmas factor by activated PTA was tested by modifying a previously described two-step method (11) . In this technique, the Christmas factor in hemophilic plasma was activated by activated PTA in the presence of calcium ions and soap. The reaction was stopped by the addition of barbital-saline-citrate buffer. The activated Christmas factor that had evolved was assayed, with Christmas-factor-deficient plasma as a substrate.
The influence of soap on the activation of Hageman factor by glass was determined by noting the clotting time of a mixture of native plasma and soap in Pyrex tubes (i.d. 11 mm) at 25°C. The effect of soap on inactive Hageman factor was obtained by determining the clotting time of a mixture of native plasma and soap in siliconecoated tubes (i.d. 11 mm) at 37°C.
The prothrombin time was measured by the one-stage method of Quick, Stanley-Brown, and Bancroft (15), using undiluted thromboplastin and thromboplastin diluted 1: 100 with barbital-saline. The Russell's viper venom time was measured by substituting Russell's viper venom, diluted 1: 10,000 with barbital-saline, for thromboplastin in the determination of the prothrombin time. The thrombin time, that is, the clotting time of a mixture of citrated plasma, bovine thrombin, and the substance to be tested, was measured by a previously described method (16) . The prothrombin time, Russell's viper venom time, and thrombin time were also measured after the mixture to be tested had been incubated with plasma for one or more minutes before addition of calcium or thrombin.
All studies wsere performed in test tubes with an i. minute, this soap shortened the clotting time of normal plasma to 6 minutes, compared with 10 minutes in its absence. In contrast, soaps of short-chain saturated or long-chain unsaturated fatty acids either were much less active or did not shorten the recalcified clotting time. In this system, the more active soaps were effective at concentrations comparable to the concentration of free fatty acids found in normal plasma (17) .
The effect of soaps on the middle and later stages of coagulation. A series of experiments was performed to determine the site of action of the clot-promoting soaps. Most of these studies were carried out with sodium arachidate. This soap, at an initial concentration of 0.0032 mEq per L, did not alter the rate at which fibrinogen was converted to fibrin by bovine thrombin, as tested by the thrombin time. One-tenth ml of soap (0.0032 mEq per L) incubated with 0.2 ml of normal citrated plasma for 5 minutes before the addition of 0.1 ml bovine thrombin (2.5 U per ml) resulted in a clotting time of 76 seconds, as compared to 71 seconds for the buffer control. Nor did it alter the rate at which prothrombin was converted to thrombin in the presence of tissue thromboplastin or Russell's viper venom (Table II) . These experiments suggested that the effect of soaps was earlier in the clotting process, perhaps affecting the rate at which thromboplastin-like activity evolved in the plasma. * One-tenth ml of plasma was incubated with 0.1 ml of Tris buffer or sodium arachidate for 9 minutes in siliconecoated tubes at 370 C. Then 0.1 ml of 0.04 M calcium chloride and 0.1 ml of normal plasma were added. The tubes were then tilted once a minute until clotting occurred.
alter the activity of Hageman factor when incubated with this substance before their addition of plasma deficient in Hageman factor (Table IV) . Similarly, these studies suggest that soaps are without effect upon inactive PTA in plasma. The experiments next to be described, however, indicate that soaps may influence the rate at which PTA is activated, either by Hageman factor, or ''spontaneously.."
The effect of soaps on activation of PTA by active Hageman factor. The soaps of long-chain saturated fatty acids were incubated with a mixture of purified activated Hageman factor and crude PTA (Table V) . This mixture was then tested for its effect upon the recalcified clotting time of PTA-deficient plasma. In confirmation of earlier studies, clot-promoting activity evolved when activated Hageman factor was incubated with PTA, an effect previously attributed to the 16 Buffer + purified activated Hageman factor 18 17 * One-tenth ml of purified activated Hageman factor (0.3 jug protein per ml) and 0.1 ml of Tris buffer or sodium stearate (0.75 mEq per L) were incubated in silicone-coated tubes at 370 C. Then 0.1 ml of 0.025 M calcium chloride and 0.1 ml of Hageman-factor-deficient plasma were added. The tubes were then tilted once a minute until clotting occurred. activation of PTA (9) . The presence of soap in the incubation mixture accelerated this reaction. Similar results were obtained when this experiment was performed eleven other times. The accelerating effect was temperature dependent. After preliminary incubation for 10 minutes at 0°C, no acceleration could be noted in this test system; at 150 C, suboptimal acceleration occurred. The effect of soap was apparently upon the activation of PTA, rather than upon activated PTA. If soap was added to activated Hageman factor and crude PTA after the period of preliminary incubation, no increase in clot-promoting activity was demonstrated (Table VI) . Moreover, the incubation of partially purified activated PTA with soap had no effect upon the coagulation of PTA- deficient plasma (Table VII) , or upon the activation of Christmas factor in hemophilic plasma (Table VIII) . The soaps of long-chain saturated fatty acids were also incubated with a mixture of purified activated Hageman factor and Hageman-factordeficient plasma. This plasma served as a source of inactive PTA. The recalcified clotting time of the mixture was then determined (Table IX) . Clot-promoting activity evolved, and the presence of soap in the incubation mixture accelerated this reaction.
The effect of soaps on crude PTA. The experiments described can be interpreted to mean either that soaps accelerate the activation of PTA by activated Hageman factor, or that they activate PTA directly. Previously, we had noted that * Two and two-tenths ml of Hageman-factor-deficient plasma, 1.1 ml barbital-saline or sodium stearate, and 1.1 ml purified activated Hageman factor (2.5 pg protein per ml) were incubated in silicone-coated tubes at 370 C. At intervals, 0.4 ml of this mixture was transferred in duplicate with silicone-coated pipettes to silicone-coated clotting tubes. Then 0.1 ml of 0.04 M calcium chloride was added, and the tubes were tilted once a minute until clotting occurred. however, under these conditions clotting was not accelerated (Table X) . The difference between the effect of soaps upon native plasma or citrated plasma may relate to the concentration of calcium at the time the soap was added. Calcium chloride solution added to citrated plasma before the addition of soaps inhibited their clotpromoting effect (Table XI) . This explanation may not be entirely satisfactory. Although the final concentration of calcium (0.0017 M) needed for inhibition in the preliminary incubation mixture was lower than that normally found in human plasma, the inhibition was not complete.
Nevertheless, calcium stearate suspended in barbital-saline buffer at an initial concentration of 2 mEq per L did not accelerate clotting significantly. After a preliminary incubation period of 5 minutes, the recalcified clotting time of a mixture of normal plasma and calcium stearate was 15 minutes, whereas that of normal plasma alone was 19 minutes. The same plasma mixed with an equivalent concentration of sodium stearate clotted in 3 minutes when tested in the same way.
Failure to demonstrate an accelerating effect of soaps on Christmas factor activation might have resulted from this inhibition by calcium ions, which are a necessary part of this experiment. The ratio of soap concentration to calcium concentration, however, should have been sufficient to permit the soaps to remain effective. Therefore, artifactual inhibition by added calcium ions should not have occurred.
The recalcified clotting time of normal plasma prepared from blood to which one-ninth vol of 0.05 M trisodium ethylenediaminetetraacetic acid (24) . Margolis showed that the clot-promoting effect of soaps could be partially inhibited by mixing the soap for 30 seconds with Hageman-factordeficient plasma before the addition of normal plasma. He interpreted these experiments to mean that the Hageman-factor-deficient plasma, known to contain inhibiting properties (22) , specifically blocked the action of soaps upon the Hageman factor contained in the normal plasma. We have been able to confirm these experiments but find in addition that the action of soaps can be inhibited equally by plasma deficient in PTA but not in Hageman factor. Whatever the mechanism through which these inhibitions occurred, then, they did not seem to depend upon the absence of Hageman factor. Interestingly, plasma obtained from patients with classic hemophilia or Christmas disease did not inhibit the action of soaps (26) . The mechanism through which soaps manifest their action upon PTA is unknown. Whether this effect is related to micelle formation as postulated by Connor (6) Margolis (24) .
Tests to determine whether soaps influenced the activation of Christmas factor by activated PTA were performed in the presence of calcium ions, since these are needed for this step to proceed (11 These experiments, then, confirm the clot-promoting effect of soaps and localize their action to the activation of PTA. What significance these observations have for the pathogenesis of thrombotic states is uncertain. The failure of soaps to accelerate the clotting of native plasma makes it seem doubtful that the free fatty acids of human plasma are of importance in the development of intravascular thrombi. The possibility is by no means ruled out, since large increases in concentration of free fatty acids in localized areas may occur and conceivably overcome inhibition to any clot-promoting effect.
SUMMARY
The in vitro procoagulant effect of the sodium soaps of long-chain saturated fatty acids appears to be due to acceleration of the activation of plasma thromboplastin antecedent (PTA). The presence of Hageman factor was not necessary for this effect, suggesting that alternate pathways for the activation of PTA exist. Calcium chloride solution partially inhibited the acceleration by soaps. The data presented suggest that the clot-promoting properties of the soaps are unlikely to be significant under the conditions present in circulating blood. Thus, the concept that the free fatty acids of human plasma are of importance in the development of intravascular thrombi seems doubtful.
